The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National ...
Natera recently announced that its Signatera minimal residual disease (MRD) test received approval from Japan’s Pharmaceuticals and Medical Devices Agency for use in colorectal cancer patients in the ...
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack ...
What years of testing thermal cameras taught me about the problems hiding in plain sight ...
With an FDA approval for its companion diagnostic in bladder cancer, Natera extends its Treatment on MRD strategy, deferring ...
I brought a Bose, Sony, and JBL speaker to the beach - this one's my new outdoor essential ...
QA expert Daniil Khudenko explains how structured quality systems improve release stability, risk management, and scalability ...
Landau, MD, discussed promising results of CAR T-cell therapy in light chain amyloidosis and the challenge of developing ...
The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and ...
When your job calls for multiple types of equipment, materials, tools, and more, you need a legitimate work van that enables ...
Black holes do their most important work in hiding. The boundary that defines them, the event horizon, seals off anything ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results